Gangliosides were extracted from purified human and porcine thyrotropin (TSH) receptors (TSH-R) and were detected by probing with an 125I-labeled sialic acidspecific lectin, Limaxflavus agglutinin. Gangliosides copurified with human and porcine TSH-R migrated between monosialoganglioside GM1 and disialoganglioside GDla. Ceramide glycanase digestion of the purified human TSH-R-associated glycolipid confimed its ganglioside nature. It was resistant to Vibrio cholerae sialidase, which digests all gangliosides except GM1, but was sensitive to Arthrobacter ureafaciens sialidase, which digests all gangliosides including GM1. These rmdings indicate that the human TSH-R contains ganglioside that
The thyrotropin (TSH) receptor (TSH-R) mediates the actions of TSH on the thyroid and is believed to be the target of autoantibodies in Graves hyperthyroidism (1, 2) . The TSH-R was recently cloned from dog and human thyroid cDNA libraries (3) (4) (5) and, like the lutropin/choriogonadotropin receptor (LH/CG-R) (6, 7) , contains seven transmembrane domains characteristic of the guanine nucleotidebinding protein (G protein)-coupled family of receptors. However, the TSH-R is distinct by virtue of its long extracellular domain containing five putative N-glycosylation sites. Indirect evidence suggests that ganglioside (sialic acid containing glycosphingolipid) is a component of the TSH-R (8) (9) (10) (11) (12) . The demonstration that the B subunit of cholera toxin, which binds to GM1 ganglioside,t could inhibit TSH binding to thyroid membranes (9) and that a homologous amino acid sequence exists in the subunits of TSH and cholera toxin (10) suggested that ganglioside was an integral component of the receptor. Based on the separation of two TSH-binding components, protein and lipid, it was proposed that the TSH-R was a complex of glycoprotein and ganglioside, each of which contributed to receptor structure and function (11) . The restoration of 125I-labeled TSH (125I-TSH) binding in a ganglioside-deficient rat thyroid tumor cell line after ganglioside incorporation into cell membranes (14) provided further evidence that the TSH-R is a glycolipidglycoprotein complex. However, direct evidence for ganglioside in the TSH-R has been lacking because of the limited availability of purified receptor and the insensitivity of ganglioside detection by resorcinol staining or anti-ganglioside antibody binding.
Several thyroid membrane gangliosides have been identified, some of which decrease the binding of 125I-TSH to thyroid membranes (12) . In the human thyroid, 70% of the gangliosides are GM3 and GD3, together with several monosialilated and disialilated gangliosides and GT1b and GQ1b (15) . Porcine thyroid gangliosides, while not as well characterized, include GD3, GM1, and GD1a but not GM3 (16) .
We have purified and characterized the human (2) and porcine (17) TSH-R by sequential wheat germ agglutinin (WGA) and TSH affinity chromatography. Purified human (from Graves and multinodular thyroid glands) and porcine TSH-R have a similar glycoprotein structure comprising proteins of Mr 70,000, 50,000, and 35,000 in the nonreduced state. Immunoblotting or immunoprecipitation with Graves disease immunoglobulins demonstrated an autoepitope in the Mr 50,000 protein of both human and porcine TSH-R (18) . In addition, we recently described (19) a highly sensitive technique for the detection of gangliosides (less than 1 ng or 0.5 pmol) by direct binding of 1251-labeled Limaxflavus agglutinin (125I-LFA) to TLC plates.
The direct demonstration of ganglioside in the TSH-R would have significant implications for receptor structure and function. We asked, therefore, whether affinity-purified human and porcine TSH-R that bind TSH and react with Graves disease immunoglobulins contain ganglioside.
MATERIALS AND METHODS Materials. Partially purified bovine TSH (10 international units per vial), Triticum vulgare WGA, N-acetyl-Dglucosamine, Triton X-100, leupeptin, phenylmethylsulphonyl fluoride, dithiothreitol, polyvinylpyrrolidone (Mr 40,000), and bovine serum albumin (RIA grade) were purchased from Sigma. lodo-Gen (1,3,4,6-tetrachloro-3a,6a-diphenylglycouril)-and 1,1'-carbonyldiimidazole-activated 6% crosslinked beaded agarose [CDI-agarose, Reacti-Gel (6x)] were obtained from Pierce. Poly-Prep chromatography columns were purchased from Bio-Rad.
LFA; bovine brain gangliosides GM2, GD1a, GD1b, GT1b, and GQ1b; and bovine erythrocyte GM3, at least 98% pure as assessed by TLC, were from Calbiochem. GM1 The lodo-Gen method (20) was used to radiolabel affinitypurified porcine or human TSH-R with 1251 to a specific activity of 2 ,uCi/,ug (1 IxCi = 37 kBq) and bovine TSH to a specific activity of =10 ,Ci/4g. LFA was iodinated by the chloramine-T method (21) to a specific activity of 25 ± 5 ixCi/,ug and was stable for at least 3 weeks at 40C.
Preparation of Membranes and Purified TSH-R. Human thyroid tissue was obtained with consent from patients undergoing surgery for multinodular goitre or Graves disease and human whole adrenal gland (control tissue) from a kidney donor subject. Porcine thyroids were obtained within 30 min after slaughter. Tissues were transported on ice and stored at -700C. Frozen tissues were solubilized, and TSH-R was purified as described (2) . All procedures were performed at 40C. Briefly, tissue was homogenized in 10 mM Tris, pH 7.4/50 mM sodium chloride (Tris/NaCI) in the presence of protease inhibitors (leupeptin at 20 gg/ml, aprotinin at 1000 kallikrein inhibitory units/ml, bacitracin at 100 units/ml, and phenylmethylsulfonyl fluoride at 2 mM). Particulate membranes were solubilized in Tris/NaCI containing Triton X-100 at 10 g/liter and protease inhibitors and were centrifuged at 100,000 x g for 1 hr. Receptors in solubilized thyroid membranes were affinity-purified on WGA-agarose, and fractions eluted from WGA-agarose that contained 125I-TSHbinding activity were adsorbed onto TSH-agarose. Purified receptors were eluted with 3 ml of 3 M NaCI/10 mM Tris-HCI, pH 7.4/1 g of Triton X-100 per liter and were dialyzed against Tris/NaCl containing Triton X-100 at 1 g/liter. Adrenal tissue was also sequentially purified on WGA-and TSH-agarose.
The protein concentration of membrane preparations was determined by the method of Bradford (22) , and the amount of purified receptor was estimated by silver staining of SDS/PAGE gels. 125I-TSH binding assays were performed as described (3) . Sequential purification produced a 1250-and 800-fold increase in 125I-TSH binding activity over that observed in human and porcine membranes, respectively. Ganglioside Detection in Porcine and Human Thyroid Tissue. Gangliosides were extracted by phase partition from equivalent quantities (-3 g) of human and porcine thyroid tissue-i.e., thyroid particulate membranes, solubilized membranes, WGA-agarose eluate, and TSH-agarose eluate as described elsewhere (19) . Both upper and lower phases were dried in a Hetovac VR-1 vacuum centrifuge. The residues were reconstituted in chloroform/methanol/water, 60:30:4.5 (vol/vol), and centrifuged at 5000 x g; the supernatants were stored at -20°C without further purification prior to TLC. To reduce diffusion and increase the glycolipid concentration applied to the TLC plate, glycolipid extracts were spotted onto the TLC plate at one point only and migrated as dots. Plates were developed in chloroform/ methanol/KCl aqueous solution (2.5 g/liter), 5:4:1 (vol/vol). After drying, the silica on the plates was prevented from detaching by soaking in hexane containing 1 g of poly(isobutyl methacrylate) per liter. The TLC plates were incubated with 1251I-LFA, washed in phosphate-buffered saline containing 10 g of polyvinylpyrrolidone per liter, dried, and exposed to Amersham hyperfilm (MP) for 48-72 hr at -70°C.
With the exception of purified receptors, all of the other thyroid membrane preparations examined were unlabeled, and gangliosides were detected by using the overlay technique described above. Purified porcine and human TSH-R were analyzed either unlabeled or labeled with 1251. Gangliosides from the latter were extracted and analyzed by TLC and autoradiography.
Gangliosides were also extracted from human adrenal tissue. (Fig. 1, lane B) , respectively. The major ganglioside detected in the WGA-agarose eluate migrated at the position of GM1 (Fig. 1, lane C) . When the extraction was performed on receptors eluted from TSHagarose in 3 M NaCl, which selectively elutes a Mr 50,000 TSH-R protein (2), a single ganglioside was detected migrating between GM1 and GD1a (Fig. 1, lane D) Iw -GM3 WGA-agarose but were not detected after subsequent TSHagarose affinity chromatography (data not shown).
Gangliosides Detected During Purification of the Porcine TSH-R. The major ganglioside in porcine thyroid particulate membranes migrated just below GD1a (Fig. 2, lane A) , while in solubilized membranes the major ganglioside migrated at the position of GM1 (Fig. 2, lane B) . After elution from WGA-agarose a ganglioside was also detected at the GM1 position (Fig. 2, lane C) . When the porcine receptor was eluted from TSH-agarose in 3 M NaCl, a single ganglioside was detected migrating between GM1 and GD1a (Fig. 2, lane  D) . The broad band below GD1a in lane D was not considered to be specific because it was present across the TLC plate as seen in the adjacent "St" lane.
Extraction of 125I-Labeled Purified Receptors. To assess the separation ofganglioside from receptor protein, human receptors purified from a multinodular thyroid gland were labeled with 125I, and glycolipids were extracted as described above. In these experiments both the upper (glycolipid-containing) and lower (protein-containing) phases recovered after the partition were analyzed by TLC and autoradiography. As expected, almost all of the 12'I radioactivity remained in the lower protein-rich phase (Fig. 3, lane B) . However, a small amount ofradioactivity in the upper phase migrated as a single spot to a position near GM1 (Fig. 3, lane A) . This radioactivity is presumably lipid-associated and may be incorporated in the double bond of the ceramide moiety of ganglioside because it was labile and could not be detected after a 12-hr exposure of the dried TLC plate to air at room temperature.
Characterization of TSH-R-Associated Ganglioside. The glycolipid extracted from purified Graves thyroid TSH-R was treated with ceramide glycanase which, in the presence of cholate, cleaves the bond between the ceramide moiety and the glucose of the glycan chain (23) . This resulted in release of the carbohydrate chain and an inability to detect ganglioside on the TLC plate (Fig. 4, lane A) , confirming the glycosphingolipid nature of TSH-R-associated glycolipid. In addition, this finding excluded galactose as the first sugar bound to the ceramide moiety. Carbohydrate released by enzymatic treatment was not detected by the LFA sialic acid probe at the plate front because the digest was reextracted before TLC and probing.
TSH-R ganglioside was further characterized by treatment with V. cholerae and A. ureafaciens sialidases. V. cholerae sialidase hydrolyzes ketosidic bonds in all gangliosides except GM1 (24) . A. ureafaciens sialidase releases sialic acid attached to an internal galactose in any ganglioside, including GM1 (25) . When TSH-R ganglioside was treated with V. cholerae sialidase, there was no change in its mobility or intensity compared with untreated ganglioside (Fig. 4, lane  B) . However, it was no longer visualized after A. ureafaciens sialidase treatment (Fig. 4, lane D) . These findings suggest that the ganglioside is a member of the GM1 family, even though it does not migrate at the exact location of the bovine brain GM1 standard on TLC plates. The variation in mobility on TLC of the TSH-R-associated ganglioside (compare lane D in Fig. 1 with lane C in Fig. 4 ) may be explained by its modification-e.g., by deacetylation or delactonization. The acidic conditions used for the sialidase experiments (Fig. 4 , lane C) can relactonize ganglioside or prevent the loss of acetyl groups prior to TLC. That the receptor-associated ganglioside can be modified is also evident by its alkali lability. Thus, when ganglioside on the TLC plate was exposed to ammonia vapor for 5 hr and then developed, it migrated below a GM1-GDla cluster (data not shown). DISCUSSION We have shown that specific gangliosides are sequentially copurified with human and porcine TSH-R. In addition, a Biochemistry: Kielczynski et al.
single ganglioside was identified that coeluted with the Mr 50,000 TSH-R protein purified from human multinodular and Graves thyroid tissue and from normal porcine thyroid tissue. These findings represent direct evidence for the intimate association of ganglioside with the TSH-R.
The ability to detect receptor-specific gangliosides is attributed to the bulk purification of receptor and the use of 125I-LFA as a probe. The binding of LFA to sialic acids within the oligosaccharide chains of glycoprotein and glycolipids allows gangliosides to be detected with a TLC overlay technique. As little as 1 ng (0.5 pmol) of bovine ganglioside standard can be detected by this technique, a sensitivity 3 orders of magnitude greater than that with the traditional resorcinol and thiobarbituric acid methods for sialic acid (26) . Salts, organic acids, and simple saccharides present in the upper phase after extraction do not interfere with binding of 125I-LFA (19) . Furthermore, the results with 125I-TSH-R show that the glycoprotein remains in the lower (protein-rich) phase.
The copurification of ganglioside with TSH-R glycoprotein after two sequential chromatography steps indicates that ganglioside and glycoprotein are linked by strong noncovalent bonds. Strong noncovalent association between lipid and protein has been described for the vitronectin receptor on melanoma cells (27) . Analysis of the recently published sequences of the human Graves (4, 5) and dog (3) TSH-R reveals a possible site for glycolipid binding. The dog and human receptors contain an 11-amino acid sequence in the extracellular domain, 62 amino acids towards the N terminus from the first transmembrane domain, with >80% and 45% homology, respectively, to the sequence of peanut agglutinin (Fig. 5) . This lectin binds the sugar sequence of Gal(ql --3)-GalNAc in glycoproteins and in only one ganglioside, GM1 (28) . Our findings indicate that a ganglioside from the GM1 family is copurified with the human TSH-R. This lectin-like sequence in the TSH-R could serve as a putative binding site for the ganglioside. Interestingly, analysis of the LH/CG-R sequence (6, 7) also reveals a similar putative'ganglioside binding site. The LH/CG-R contains a sequence with partial homology to another lectin, soybean (Glycine max) agglutinin, which is specific for GalNAc residues. GM2 is the only ganglioside that binds to soybean agglutinin (28) . Although gangliosides have been implicated in LH (29) and CG (30) binding, a definitive LH/CG-R-associated ganglioside has not been identified.
Calcium may play a crucial role in the formation and/or stabilization of the TSH-R glycoprotein-ganglioside complex. Calcium has been directly implicated in the association of gangliosides with proteins (31), and both peanut and soybean lectins require calcium for binding (32) . Calciumbinding proteins contain' amino acid sequences in which alternate residues within a 9-to 12-residue loop provide oxygen ligands essential for metal binding (33) . It may be relevant, therefore, that the dog and human TSH-R contain specific residues within the putative ganglioside-binding site that could donate oxygen ligands for calcium binding (Fig. 5 ). However, most of the carbohydrate and calcium-binding proteins identified to date contain separate carbohydrate and calcium-binding sites (32) . As the amino acid sequence shown in Fig. 5 could represent a calcium-binding site, we searched the human TSH-R sequence for another putative gangliosidebinding site. It has been shown that tryptophan is critical for binding of the B subunit of cholera toxin to GM1 (34) . The human TSH-R contains two extracellular tryptophan residues (4). The first, at amino acid residue 237, is not present in the LH/CG-R sequences (6, 7) , while the second, at amino acid residue 467, is in the short loop between the second and third transmembrane domains. Other charged residues potentially important for carbohydrate-protein interaction (35) are also present within this loop.
If calcium were required for ganglioside binding to the TSH-R glycoprotein, one might predict that calcium-specific chelating agents would dissociate the complex. In preliminary experiments, we have obtained evidence to support this prediction, using TSH-R purified from the rat thyroid cell line FRTL-5. TSH-R was eluted in 3 M NaCl from TSH affinity columns either untreated or extensively prewashed with 10 mM EGTA. Receptor eluted without prior EGTA treatment had a Mr of 55,000, compared with 50,000 after EGTA treatment of the column. When both receptors were extracted, a ganglioside was identified only in the former, suggesting that EGTA dissociated ganglioside from receptor protein bound to the TSH column, which was then eluted with a slightly lower molecular weight in 3 M NaCl.
The ganglioside copurified with the human TSH-R migrated between GM1 and GD1a on TLC. It was not sensitive to V. cholerae sialidase but was sensitive to A. ureafaciens sialidase, which implies that it belongs to the GM1 family of gangliosides. This family, taking into consideration the carbohydrate moiety only, includes GM1, GM1b, Fuc-GM1, LM1 (lacto-series ganglioside), 0-acetylated gangliosides (4,7,8,9-0-acetylated from each of the above groups), and 0-methylated and sulfated gangliosides. Additionally, sialic acid can be linked via 2 3 or 2 -+ 6 bonds to galactose and possibly to galactosamine (36) . Because the exact structure of the TSH-R ganglioside is not known, we can only speculate about its carbohydrate composition. It is of interest that fucosylated GM1 has been described in bovine (37) and human (26, 38) thyroids as a minor ganglioside, as were 0-acetylated gangliosides. O-acetylated gangliosides are stronger immunogens than parent ganglioside molecules (39) and have been implicated as putative autoantigens in human melanoma cells (27) and in diabetes mellitus (40) . The human TSH-R ganglioside could also be a lactone of a polysialylated ganglioside, which can be detected by LFA (W.K., unpublished data). GD1b was originally found to be the strongest bovine ganglioside inhibitor of TSH binding (10) , and GD1b lactone migrates below GM1 (41). Ganglioside lactones have been shown to occur naturally in the nervous system of rodents (42) and in human brain (41) . GD1b lactone would also be resistant to V. cholerae sialidase because of its blocked carboxyl group vicinal to the a-ketosidic linkage, but in contrast to our findings with the purified TSH-R ganglioside, it should be resistant to A. ureafaciens sialidase (41) .
There are several reports (9) (10) (11) (12) 14) that ganglioside mixtures inhibit the binding of TSH to solubilized receptor preparations and that some ganglioside fractions contain TSH-binding activity. Initially, a ganglioside from bovine thyroid membranes, containing two sialic acids and migrating at GM3, was shown to inhibit TSH binding (12) . A GM2 ganglioside from solubilized rat thyroid cell line (FRTL-5) membranes was then coprecipitated with a TSH-R glycoprotein by monoclonal antibodies that mimicked the bioeffect of TSH (43) . These studies did not identify a specific receptorassociated ganglioside because they employed impure receptor preparations and relatively insensitive methods for ganProc. Natl. Acad. Sci. USA 88 (1991) glioside detection. The present direct evidence that ganglioside may be an integral component of the TSH-R and the evidence that gangliosides modulate signal transduction events at the cell membrane (44, 45) imply a key role for ganglioside in TSH-R structure and function.
